Żvezja - Svediż - Läkemedelsverket (Medical Products Agency)

orifarm ab - glatirameracetat - injektionsvätska, lösning i förfylld spruta - 40 mg/ml - mannitol hjälpämne; glatirameracetat 40 mg aktiv substans

Unjoni Ewropea - Svediż - EMA (European Medicines Agency)

teva b.v. - salmeterol xinafoate, flutikasonpropionat - astma - läkemedel mot obstruktiv lungsjukdom, - bropair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.

Unjoni Ewropea - Svediż - EMA (European Medicines Agency)

teva b.v. - fluticasone propionate, salmeterol xinafoate - astma - läkemedel mot obstruktiv lungsjukdom, - seffalair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.